Order Article Reprints

Mauro FR, Giannarelli D, Galluzzo CM, Visentin A, Frustaci AM, Sportoletti P, Vitale C, Reda G, Gentile M, Levato L, et al. Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. Cancers. 2023; 15(11):2993. https://doi.org/10.3390/cancers15112993

Mauro, Francesca R., Diana Giannarelli, Clementina M. Galluzzo, Andrea Visentin, Anna M. Frustaci, Paolo Sportoletti, Candida Vitale, Gianluigi Reda, Massimo Gentile, Luciano Levato, and et al. 2023. "Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study" Cancers 15, no. 11: 2993. https://doi.org/10.3390/cancers15112993

Mauro, F. R., Giannarelli, D., Galluzzo, C. M., Visentin, A., Frustaci, A. M., Sportoletti, P., Vitale, C., Reda, G., Gentile, M., Levato, L., Murru, R., Armiento, D., Molinari, M. C., Proietti, G., Pepe, S., De Falco, F., Mattiello, V., Barabino, L., Amici, R., ... Baroncelli, S. (2023). Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. Cancers, 15(11), 2993. https://doi.org/10.3390/cancers15112993